Gene expression analysis of renal carcinoma: adipose differentiation‐related protein as a potential diagnostic and prognostic biomarker for clear‐cell renal carcinoma
- 28 January 2005
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 205 (3) , 377-387
- https://doi.org/10.1002/path.1693
Abstract
The gene expression profiles of 33 renal cell carcinomas (RCCs) and nine normal kidney samples were examined using high‐density oligonucleotide microarrays in an attempt to identify biomolecular markers for the diagnosis of tumour subtypes and also for prediction of prognosis. Hierarchical clustering demonstrated that clear‐cell RCC, chromophobe RCC, and normal kidney tissue showed distinctive gene expression profiles. The mean expression levels of 149 of 12 500 genes were more than three times higher in clear‐cell RCC than in chromophobe RCC and normal kidney tissue. Among the genes whose expression was upregulated in clear‐cell RCC, adipose differentiation‐related protein (ADFP) and nicotinamide N‐methyltransferase (NNMT) were selected for further analysis. Consistent with the results of the microarray, increased levels of ADFP and NNMT mRNA were found more frequently in clear‐cell RCCs than in other non‐clear‐cell tumour subtypes using real‐time quantitative PCR. Immunohistochemistry for ADFP showed strong and unique tumour cell staining patterns in the majority of clear‐cell RCCs. More importantly, patients bearing tumours with higher AFDP mRNA levels showed significantly better survival in both univariate and multivariate analyses. ADFP is a lipid storage droplet‐associated protein and its transcription is considered to be regulated by the von Hippel–Lindau/hypoxia‐inducible factor pathway. It is known that clear‐cell RCC contains abundant lipids and cholesterols. Thus it is likely that sustained upregulation of ADFP following VHL inactivation is involved in the morphological appearance of clear‐cell RCC. Moreover ADFP expression status may provide useful prognostic information as a biomolecular marker in patients with clear‐cell RCC. Copyright © 2005 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.Keywords
This publication has 33 references indexed in Scilit:
- Studying Cancer Families to Identify Kidney Cancer GenesAnnual Review of Medicine, 2003
- Expression Profiling of Renal Epithelial NeoplasmsThe American Journal of Pathology, 2001
- Mechanism of regulation of the hypoxia-inducible factor-1alpha by the von Hippel-Lindau tumor suppressor proteinThe EMBO Journal, 2000
- Hypoxia Inducible Factor-α Binding and Ubiquitylation by the von Hippel-Lindau Tumor Suppressor ProteinJournal of Biological Chemistry, 2000
- High Density Lipoprotein-mediated Cholesterol Uptake and Targeting to Lipid Droplets in Intact L-cell FibroblastsJournal of Biological Chemistry, 2000
- SYSTEMIC THERAPY FOR RENAL CELL CARCINOMAJournal of Urology, 2000
- Hereditary and Sporadic Papillary Renal Carcinomas with c-met Mutations Share a Distinct Morphological PhenotypeThe American Journal of Pathology, 1999
- Mutations of the VHL tumour suppressor gene in renal carcinomaNature Genetics, 1994
- Identification of the von Hippel-Lindau Disease Tumor Suppressor GeneScience, 1993
- Human liver nicotinamide N-methyltransferase: Ion-pairing radiochemical assay, biochemical properties and individual variationClinica Chimica Acta; International Journal of Clinical Chemistry, 1990